Loading clinical trials...
Loading clinical trials...
Metabolomics of Neurocognitive Risk for Dementia in Diabetes
Conditions
Locations
1
United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Start Date
September 9, 2019
Primary Completion Date
May 23, 2023
Completion Date
May 23, 2023
Last Updated
December 5, 2023
NCT07224321
NCT01399385
NCT07536516
NCT06513026
NCT06815081
NCT06807190
Lead Sponsor
Wake Forest University Health Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions